Delphine Legoupil

Rennes, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCA.

Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCA.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 22, 2025

Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS).

Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS).

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 22, 2025

Prognostic value of TMTV and Dmax calculated from 18F-fluorodeoxyglucose positron emission tomography images in metastatic cutaneous melanoma treated with immune checkpoint blockade.

Prognostic value of TMTV and Dmax calculated from 18F-fluorodeoxyglucose positron emission tomography images in metastatic cutaneous melanoma treated with immune checkpoint blockade.

Journal: European journal of nuclear medicine and molecular imaging

Published: July 30, 2025

18F-FDG PET radiomic analysis to predict outcomes in metastatic melanoma treated with immune checkpoint inhibitors.

18F-FDG PET radiomic analysis to predict outcomes in metastatic melanoma treated with immune checkpoint inhibitors.

Journal: Frontiers in immunology

Published: June 06, 2025

MHC class II: a predictor of outcome in melanoma treated with immune checkpoint inhibitors.

MHC class II: a predictor of outcome in melanoma treated with immune checkpoint inhibitors.

Journal: Melanoma research

Published: February 13, 2025

Brain metastases from Merkel cell carcinoma: A nationwide retrospective study.

Brain metastases from Merkel cell carcinoma: A nationwide retrospective study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 12, 2025

Real-life effectiveness on overall survival of continued immune checkpoint inhibition following progression in advanced melanoma: estimation from the Melbase cohort.

Real-life effectiveness on overall survival of continued immune checkpoint inhibition following progression in advanced melanoma: estimation from the Melbase cohort.

Journal: Melanoma research

Published: November 11, 2024

Real-world outcomes of adjuvant therapies in stage III/IV melanoma: Insights from the French RIC-MEL cohort.

Real-world outcomes of adjuvant therapies in stage III/IV melanoma: Insights from the French RIC-MEL cohort.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: November 05, 2024

Methods of nivolumab administration in advanced melanoma: A comparison of patients' clinical outcomes treated with flat dose or weight-adjusted dose, a multicenter observational study.

Methods of nivolumab administration in advanced melanoma: A comparison of patients' clinical outcomes treated with flat dose or weight-adjusted dose, a multicenter observational study.

Journal: Cancer

Published: August 08, 2024

Efficacy and Tolerability of Tebentafusp in Metastatic Uveal Melanoma: A Real-life Retrospective Multicentre Study.

Efficacy and Tolerability of Tebentafusp in Metastatic Uveal Melanoma: A Real-life Retrospective Multicentre Study.

Journal: Acta dermato-venereologica

Published: August 06, 2024

The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab + nivolumab vs. nivolumab in a real-world setting.

The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab + nivolumab vs. nivolumab in a real-world setting.

Journal: The British journal of dermatology

Published: July 17, 2024

Pustular mycosis fungoides has a poor outcome: a multicentric clinicopathological and molecular case series.

Pustular mycosis fungoides has a poor outcome: a multicentric clinicopathological and molecular case series.

Journal: The British journal of dermatology

Published: May 07, 2024

Showing 1-12 of 47

Last Updated: 09/26/2026